QLGN logoQLGN
Qualigen Therapeutics Inc

37,150
Loading...
Loading...
Qualigen Therapeutics, Inc. is a biotechnology company focused on developing therapeutics for the treatment of cancer and infectious diseases. The company's cancer therapeutics pipeline includes ALAN (AS1411-GNP), RAS-F3 and STARS. ALAN (AS1411-GNP) is a DNA coated gold nanoparticle cancer drug candidate that has the potential to target various types of cancer with minimal side effects. RAS-F3 is a small molecule RAS oncogene protein-protein inhibitor for blocking RAS mutations that lead to tumor formation, especially in pancreatic, colorectal and lung cancers. STARS is a DNA/RNA-based treatment device for removal from circulating blood of precisely targeted tumor-produced and viral compounds. The company was founded on March 29, 2004 and is headquartered in Carlsbad, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Qualigen Therapeutics Inc?
What is the 52-week high for Qualigen Therapeutics Inc?
What is the 52-week low for Qualigen Therapeutics Inc?
What is Qualigen Therapeutics Inc stock price today?
What was Qualigen Therapeutics Inc stock price yesterday?
What is the PE ratio of Qualigen Therapeutics Inc?
What is the Price-to-Book ratio of Qualigen Therapeutics Inc?
What is the 50-day moving average of Qualigen Therapeutics Inc?

Latest QLGN News

View

Advertisement. Remove ads.

Advertisement. Remove ads.